Utilization of primary health care services among Syrian refugee and Lebanese women targeted by the ICRC program in Lebanon: a cross-sectional study von Truppa, Claudia, Leresche, Enrica, Fuller, Arlan F, Marnicio, Ariana S, Abisaab, Josyann, El Hayek, Nicole, Zmeter, Carla, Toma, Warda S, Harb, Hilda, Hamadeh, Randa S, Leaning, Jennifer

Volltext

The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990–1999) at the Massachusetts General Hospital von Dinh, Tri A, Oliva, Esther A, Fuller, Arlan F, Lee, Hang, Goodman, Annekathryn

Volltext

Uterine Smooth-Muscle Tumors with Unusual Growth Patterns: Imaging with Pathologic Correlation von Cohen, Daniel T, Oliva, Esther, Hahn, Peter F, Fuller, Arlan F., Jr, Lee, Susanna I

Volltext

Expression of multidrug resistance-1 protein inversely correlates with paclitaxel response and survival in ovarian cancer patients: a study in serial samples von Penson, Richard T, Oliva, Esther, Skates, Steven J, Glyptis, Tina, Fuller, Arlan F, Goodman, Annekathryn, Seiden, Michael V

Volltext

Endometrial Cancer in Women 40 Years Old or Younger von Duska, Linda R, Garrett, Audrey, Rueda, Bo R, Haas, Jacqueline, Chang, Yuchiao, Fuller, Arlan F

Volltext

Epithelioid angiosarcoma of the uterus: a review of management von Olawaiye, Alexander B., Morgan, Jeffrey A., Goodman, AnneKathryn, Fuller, Arlan F., Penson, Richard T.

Volltext

Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer von Sainz de la Cuesta, Ricardo, Eichhorn, John H., Rice, Laurel W., Fuller, Jr, Arlan F., Nikrui, Najmosama, Goff, Barbara A.

Volltext

Ten‐year follow‐up of a phase 2 study of dose‐intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor‐prognosis, advanced‐stage epithelial ovarian cancer... von Sarosy, Gisele A., Hussain, Mahrukh M., Seiden, Michael V., Fuller, Arlan F., Nikrui, Najmosama, Goodman, Annekathryn, Minasian, Lori, Reed, Eddie, Steinberg, Seth M., Kohn, Elise C.

Volltext

Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis von Houck, Karen, Nikrui, Najmosama, Duska, Linda, Chang, Yuchiao, Fuller, Arlan F, Bell, Debra, Goodman, Annekathryn

Volltext

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors von Campos, Susanna M, Matulonis, Ursula A, Penson, Richard T, Lee, Hang, Berkowitz, Ross S, Duska, Linda R, Fuller, Arlan F, Wilson, Kara S, Puchalski, Thomas A, Supko, Jeffrey G, Seiden, Michael V

Volltext

Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies von Penson, Richard T, Seiden, Michael V, Goodman, Annekathryn, Fuller, Arlan F, Berkowitz, Ross S, Matulonis, Ursula A, Krasner, Carolyn, Lee, Hang, Atkinson, Tina, Campos, Susana M

Volltext

Long-Acting Octreotide for the Treatment and Symptomatic Relief of Bowel Obstruction in Advanced Ovarian Cancer von Matulonis, Ursula A., Seiden, Michael V., Roche, Maria, Krasner, Carolyn, Fuller, Arlan F., Atkinson, Tina, Kornblith, Alice, Penson, Richard

Volltext

Paclitaxel and Platinum Chemotherapy for Malignant Mixed Mullerian Tumors of the Ovary von Duska, Linda R., Garrett, Audrey, Eltabbakh, Gamal H., Oliva, Esther, Penson, Richard, Fuller, Arlan F.

Volltext

Phase II trial of anastrozole in women with asymptomatic müllerian cancer von Carmen, Marcela G.del, Fuller, Arlan F, Matulonis, Ursula, Horick, Nora K, Goodman, Annekathryn, Duska, Linda R, Penson, Richard, Campos, Susana, Roche, Maria, Seiden, Michael V

Volltext

Epithelial ovarian carcinoma in the reproductive age group von Duska, Linda R., Chang, YuChiao, Flynn, Cynthia E., Chen, Annette H., Goodman, Annekathryn, Fuller, Arlan F., Nikrui, Najmosama

Volltext

The Clinical Utility of Liposomal Doxorubicin in Recurrent Ovarian Cancer von Campos, Susana M., Penson, Richard T., Mays, Aisha R., Berkowitz, Ross S., Fuller, Arlan F., Goodman, Annekathryn, Matulonis, Ursula A., Muzikansky, Alona, Seiden, Michael V.

Volltext

Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS von MASIAKOS, P. T, MACLAUGHLIN, D. T, PREFFER, F. I, DONAHOE, P. K, MAHESWARAN, S, TEIXEIRA, J, FULLER, A. F, SHAH, P. C, KEHAS, D. J, KENNEALLY, M. K, DOMBKOWSKI, D. M, HA, T. U

Volltext

Clear Cell Carcinoma of the Ovary: A Distinct Histologic Type with Poor Prognosis and Resistance to Platinum-Based Chemotherapy in Stage III Disease von Goff, Barbara A., Sainz de la Cuesta, Ricardo, Muntz, Howard G., Fleischhacker, Deborah, Ek, Marit, Rice, Laurel W., Nikrui, Najmosama, Tamimi, Hisham K., Cain, Joanna M., Greer, Benjamin E., Fuller Jr, Arlan F.

Volltext

Prognostic Importance of Intraoperative Rupture of Malignant Ovarian Epithelial Neoplasms von de la CUESTA, RICARDO SAINZ, GOFF, BARBARA A, FULLER, ARLAN F, NIKRUI, NAJMOSAMA, EICHHORN, JOHN H, RICE, LAUREL W

Volltext

Mortality in Puerto Rico after Hurricane Maria von Kishore, Nishant, Marqués, Domingo, Mahmud, Ayesha S, Kiang, Mathew Vinhhoa, Rodriguez, Irmary, Fuller, Arlan F, Ebner, Peggy, Sorensen, Cecilia, Racy, Fabio De Castro Jorge, Lemery, Jay, Maas, Leslie, Leaning, Jennifer, Irizarry, Rafael A, Balsari, Satchit Siddharth, Buckee, Caroline O'Flaherty

Volltext